Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect
- 1 May 1995
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 95 (5), 551-556
- https://doi.org/10.1007/bf00223868
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: Correlations with phenotypeHuman Mutation, 1995
- Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau DiseaseNew England Journal of Medicine, 1993
- Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3pHuman Molecular Genetics, 1992
- Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locusHuman Genetics, 1991
- Diagnosis of genetic disease by primer-specified restriction map modification, with application to cystic fibrosis and retinitis pigmentosaThe Lancet, 1991
- Clinical Features and Natural History of von Hippel-Lindau DiseaseQJM: An International Journal of Medicine, 1990
- Specific Genetic Change in Tumors Associated With von Hippel-Lindau DiseaseJNCI Journal of the National Cancer Institute, 1989
- Renal pathology in von Hippel-Lindau diseaseHuman Pathology, 1988
- BASIC CRITERIA FOR CLINICAL-DIAGNOSIS AND GENETIC-COUNSELING IN VONHIPPEL-LINDAU SYNDROME1987
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971